- Home
- ACRV vs VIVK Comparison
ACRV vs VIVK Comparison
Compare ACRV & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- VIVK
- Stock Information
- Founded
- ACRV 2018
- VIVK 2006
- Country
- ACRV United States
- VIVK United States
- Employees
- ACRV N/A
- VIVK N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- VIVK Oilfield Services/Equipment
- Sector
- ACRV Health Care
- VIVK Energy
- Exchange
- ACRV Nasdaq
- VIVK Nasdaq
- Market Cap
- ACRV 47.8M
- VIVK 38.4M
- IPO Year
- ACRV 2022
- VIVK N/A
- Fundamental
- Price
- ACRV $1.56
- VIVK $0.56
- Analyst Decision
- ACRV Buy
- VIVK
- Analyst Count
- ACRV 6
- VIVK 0
- Target Price
- ACRV $17.75
- VIVK N/A
- AVG Volume (30 Days)
- ACRV 3.5M
- VIVK 246.1K
- Earning Date
- ACRV 11-12-2025
- VIVK 08-19-2025
- Dividend Yield
- ACRV N/A
- VIVK N/A
- EPS Growth
- ACRV N/A
- VIVK N/A
- EPS
- ACRV N/A
- VIVK N/A
- Revenue
- ACRV N/A
- VIVK $124,048,464.00
- Revenue This Year
- ACRV N/A
- VIVK N/A
- Revenue Next Year
- ACRV $805.34
- VIVK N/A
- P/E Ratio
- ACRV N/A
- VIVK N/A
- Revenue Growth
- ACRV N/A
- VIVK 98.83
- 52 Week Low
- ACRV $1.05
- VIVK $0.51
- 52 Week High
- ACRV $8.74
- VIVK $1.89
- Technical
- Relative Strength Index (RSI)
- ACRV 58.63
- VIVK 31.97
- Support Level
- ACRV $1.46
- VIVK $0.51
- Resistance Level
- ACRV $2.67
- VIVK $0.64
- Average True Range (ATR)
- ACRV 0.19
- VIVK 0.08
- MACD
- ACRV 0.01
- VIVK -0.01
- Stochastic Oscillator
- ACRV 18.98
- VIVK 12.39
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.